Cipher Pharmaceuticals Inc

PHE

Company Profile

  • Business description

    Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

  • Contact

    5750 Explorer Drive
    Suite 404
    MississaugaONL4W 0A9
    CAN

    T: +1 905 602-5840

    E: [email protected]

    https://www.cipherpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    6

Stocks News & Analysis

stocks

Coinbase Earnings: Weak Cryptocurrency Prices Lead to Lower Trading Volume and Net Losses - Clone

We’ve lowered our fair value estimate of Coinbase stock.
stocks

Higher dividend for ASX member of our income pick list

Management lifted guidance and full-year dividend.
stocks

We expect sales growth to moderate for overvalued ASX share

Shares rallied after results but we see future headwinds.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,182.5022.30-0.24%
CAC 408,324.377.870.09%
DAX 4024,765.3735.54-0.14%
Dow JONES (US)49,500.9348.950.10%
FTSE 10010,507.0533.360.32%
HKSE26,705.94138.820.52%
NASDAQ22,546.6750.48-0.22%
Nikkei 22556,566.49239.92-0.42%
NZX 50 Index13,031.6286.29-0.66%
S&P 5006,836.173.410.05%
S&P/ASX 2008,958.9020.40-0.23%
SSE Composite Index4,082.0751.95-1.26%

Market Movers